Akeso (HKG:9926) granted 7,115,000 share options to 114 grantees under its share option scheme at an exercise price of HK$84.60 apiece, according to a Monday filing with the Hong Kong bourse.
Chairperson Xia Yu is entitled to 3 million share options, the filing said.
The biopharmaceutical company will also offer 3,420,000 restricted share units to 107 grantees, including Xia, who will be entitled to 2 million RSUs, and six other directors.
The closing price of the shares is HK$83.15 per share, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。